Disposals:
Accenture Plc (NYSE:ACN) CEO David Rowland sold 2,883 shares
of the firm’s stock in a transaction dated Friday, January 25th. The stock was
sold at an average price of $151.75, for a total value of $437,495.25.
Following the transaction, the chief executive officer now owns 27,367 shares
in the company, valued at approximately $4,152,942.25. The sale was disclosed
in a document filed with the Securities & Exchange Commission, which is
available at this hyperlink.
David Rowland also recently made the following trade(s):
On Friday, January 18th, David Rowland sold 2,916 shares of
Accenture stock. The stock was sold at an average price of $150.00, for a total
value of $437,400.00.
Shares of NYSE ACN traded up $1.70 during mid-day trading on Friday,
reaching $151.85. 1,742,762 shares of the company’s stock were exchanged,
compared to its average volume of 2,103,674. The firm has a market cap of
$98.95 billion, a P/E ratio of 22.53, a P/E/G ratio of 2.00 and a beta of 1.10.
Accenture Plc has a twelve month low of $132.63 and a twelve month high of
$175.64. Read more …
Baxter International Inc (NYSE:BAX) Director Thomas T.
Stallkamp sold 3,187 shares of Baxter International stock in a transaction that
occurred on Friday, January 18th. The shares were sold at an average price of
$70.00, for a total value of $223,090.00. Following the completion of the
transaction, the director now owns 9,418 shares of the company’s stock, valued
at $659,260. The sale was disclosed in a legal filing with the Securities &
Exchange Commission, which can be accessed through the SEC website. Shares of BAX traded down $0.02 during mid-day trading on Wednesday,
reaching $69.64. 2,834,424 shares of the company’s stock traded hands, compared
to its average volume of 4,151,867. The stock has a market cap of $37.59
billion, a PE ratio of 28.08, a price-to-earnings-growth ratio of 1.76 and a
beta of 0.96. The company has a current ratio of 2.60, a quick ratio of 1.96
and a debt-to-equity ratio of 0.38. Baxter International Inc has a 12 month low
of $61.05 and a 12 month high of $78.38. Read more …
Hershey Co (NYSE:HSY) CEO Michele Buck sold 1,500 shares of
Hershey stock in a transaction on Tuesday, January 22nd. The stock was sold at
an average price of $108.19, for a total transaction of $162,285.00. Following
the completion of the transaction, the chief executive officer now directly
owns 166,394 shares of the company’s stock, valued at approximately
$18,002,166.86. The transaction was disclosed in a legal filing with the
Securities & Exchange Commission, which is available through the SEC website.
Michele Buck also recently made the following trade(s):
On Thursday, December 20th, Michele Buck sold 1,500 shares
of Hershey stock. The stock was sold at an average price of $106.68, for a
total transaction of $160,020.00.
On Tuesday, November 20th, Michele Buck sold 1,500 shares of
Hershey stock. The stock was sold at an average price of $107.86, for a total
transaction of $161,790.00.
Shares of HSY opened at $105.37 on Friday. Hershey Co has a 1 year
low of $89.10 and a 1 year high of $111.81. The firm has a market cap of $22.71
billion, a PE ratio of 22.14, a PEG ratio of 2.25 and a beta of 0.18. The
company has a debt-to-equity ratio of 2.60, a current ratio of 1.01 and a quick
ratio of 0.69. Read more …
UnitedHealth Group Inc (NYSE:UNH) Director William C.
Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that
occurred on Tuesday, January 22nd. The stock was sold at an average price of
$266.61, for a total transaction of $1,333,050.00. Following the sale, the
director now owns 77,702 shares in the company, valued at $20,716,130.22. The
sale was disclosed in a document filed with the SEC, which is accessible
through the SEC website. NYSE UNH opened at $266.13 on Friday. The company has a
debt-to-equity ratio of 0.64, a quick ratio of 0.69 and a current ratio of
0.73. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high
of $287.94. The company has a market capitalization of $255.60 billion, a PE
ratio of 20.66, a price-to-earnings-growth ratio of 1.36 and a beta of 0.88. Read more …
No comments:
Post a Comment